AstraZeneca will pay $2.4 billion for oncology drug developer Fusion
AstraZeneca (AZ) agreed on the purchase of the biopharmaceutical company Fusion Pharmaceuticals, which is developing a new generation of radioconjugates...
AstraZeneca (AZ) agreed on the purchase of the biopharmaceutical company Fusion Pharmaceuticals, which is developing a new generation of radioconjugates...
AstraZeneca (AZ) agreed on the purchase of the American biopharmaceutical company Icosavax, which is developing vaccines against respiratory viral diseases....
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
The Slovenian pharmaceutical company KRKA, operating in Russia, has achieved a retrial in the Presidium of the Intellectual Rights Court...
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in...
Pharmaceutical company AstraZeneca will conduct the second phase of pre-registration study of a new drug for the prevention of coronavirus...
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in...
Despite the reduction in the activity of international pharmaceutical companies in Russia, they continue to defend their patents. So, AstraZeneca...
british AstraZeneca invited the Ministry of Health and the Federal Antimonopoly Service to revise the principles of pricing for generics...
AstraZeneca (AZ) is considering spinning off its China business into a separate company with a listing in Hong Kong. This...
In 1997 he graduated from Novosibirsk State University with a degree in chemistry. In 1998, he began his career at...
The market capitalization of the British pharmaceutical company AstraZeneca has reached £189 billion ($234 billion), making it the largest company...
AstraZeneca (AZ) agreed on the acquisition of the American biotechnology company CinCor Pharma, which specializes in the development of new...
The Russian pharmaceutical company R-Pharm has suspended production of AstraZeneca's coronavirus vaccine for export due to lack of demand. This...